On July 20, 2010
FTC’s Heart May Be in Right Place on High Drug Prices, but Its Logic Is Not
The FTC’s screwed-up attempt to persuade Watson Pharmaceuticals (WPI) to do a deal with Apotex on a promise that it would end an investigation of Watson moves the FTC’s crusade against “pay-for-delay” deals from Quixotic Mode into Kamikaze Mode. It’s
…
0 Comments